21 results
8-K
EX-99.2
PRPO
Precipio Inc
3 Mar 21
Mr. Richard Sandberg is appointed Chairman of Precipio’s Board of Directors
4:30pm
excited to join the Precipio board as the team embarks on that same mission for physicians managing patients with various forms of blood cancers … .
“The work that Precipio is doing today to build valuable diagnostic products that will continue to drive the core mission of eradicating medical
8-K
EX-99.1
PRPO
Precipio Inc
2 Jan 24
Precipio Announces Christina Valauri joins the Board of Directors
5:01pm
BioVenture eLab where she applies her skills and experience in life sciences and business to support the organization’s mission to foster an entrepreneurial … . Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services. Our
8-K
EX-99.1
PRPO
Precipio Inc
14 Jan 15
Regulation FD Disclosure
12:00am
this information, including any forward - looking statements, unless required by law.
3 Our Mission Advancing personalized medicine with ICE COLD - PCR … Diagnostics
4 Three Business Units with One Mission Taking personalized medicine from concept to practice: precise, simple, convenient and affordable
8-K
EX-99.1
PRPO
Precipio Inc
11 Dec 14
Regulation FD Disclosure
12:00am
, including any forward - looking statements, unless required by law.
3 Our Mission Advancing personalized medicine with ICE COLD - PCR G roundbreaking … & patient outcomes
24 Our Mission Advancing personalized medicine with ICE COLD - PCR G roundbreaking molecular testing technology Neurology Cardiology
8-K
EX-99.1
PRPO
Precipio Inc
26 Mar 24
Precipio Announces Year end 2023 Shareholder Update Call
4:34pm
biotechnology company focused on cancer diagnostics. Our mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form
8-K
EX-99.1
54gdold5m qo
20 Jun 19
Precipio CEO Provides Update Letter To Shareholders
5:03pm
424B5
9pp6en3 fe
9 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
aenmy1 ku
2 Apr 21
Prospectus supplement for primary offering
2:00pm